|
Double trouble: South African study on dual HIV
infections highlights superinfection risk
Theo
Smart
11 August
2003
http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2239
Researchers from the University of Cape Town
have found further evidence suggesting that patients who
become infected by more than one strain of HIV prior to
seroconversion (antibody formation) are more likely to
progress rapidly to AIDS. Earlier this year, at the
Tenth Conference on Retroviruses and Opportunistic
Infections in Boston, researchers from the University of
Washington reported
similar findings in four individuals with dual HIV
infection who had progressed to AIDS or death within two
years of infection. One of those patients had been
from South Africa.
A researcher from the University of Cape Town,
Mr. Jandre Grobler, presented data on four dual
infections from a South African cohort in an oral
session on Monday at the South African AIDS Conference
in Durban.
Dual infection can be a consequence of either
co-transmission (infection with two strains at the same
time or very close to each other before seroconversion)
or superinfection (when a second HIV infection occurs in
an already infected person). The viruses are not always
by different HIV subtypes. The two viruses may in fact
be from the same subtype, though genetically highly
divergent from each other.
“Detection of dual infection is becoming more
common, especially in regions where multiple subtypes
are circulating,” said Mr. Grobler. “Furthermore,”
he added, “dual infection commonly leads to
recombinant stains and the high numbers of unique
recombinant forms of HIV in circulation suggest that
dual infection and recombination may occur
frequently.”
To determine the incidence and natural history
of dual HIV infection, researchers recruited a cohort of
32 women sex workers who had all been participants in a
Phase III study of nonoxynol-9 (Van Damme et al., Lancet
2002; 360: 971-7.). The sex workers were recruited at
five truck stops between Johannesburg and Durban. All
had received monthly monitoring during the microbicide
study. This was a very high-risk cohort. In an average
week prior to seroconversion, the women serviced about
15 clients — 59% of whom were reported to be positive.
The women reported using condoms only about 20% of the
time (Ramjee, G et al. 2001. MRC News 32:14-15.)
Twenty-eight of the women enrolled in the dual
infection study within at least 6 months of
seroconversion. Populations were tracked over time using
the heteroduplex-tracking assay to determine the
diversity of their viral populations. Data for changes
in viral load, CD4 counts and viral diversity are
available for 22 of the women out to 24 months.
Dual infections were detected in 12% of the
cohort (4/32). In these four, dual infection occurred
prior (or very shortly after) to seroconversion, and
thus most likely represent cases of co-transmission
rather than superinfection).
After dual infection, the viruses recombined to
form new hybrid viruses in each of the dually infected
patients. However, their respective viral populations
displayed different evolutionary patterns. In one
patient, the recombinant strain became dominant, in two
others the dominant population varied, while in the
fourth patient, the recombinant strain persisted as a
minority strain. At present, the significance of these
findings is unknown.
During primary infection, people who are
infected with a single strain of HIV, the virus tends to
evolve a variety of mutant populations during the first
few months until the immune system recognises HIV and
brings it under control (at setpoint), leaving a viral
population that is once again more homogenous. However,
each of the four dually infected women continued to have
viral populations that were more diverse than those in
the rest of the cohort.
This viral diversity was associated with an
inability to achieve a low viral load setpoint. While
the majority of infected women were able to establish a
low viral load set point by month 12, the four dually
infected women all had significantly higher viral loads
than had the other subjects, ranging between ~30,000 and
~500,000 copies (p=0.0056). Such viral loads are rather
high for women, and high viral loads at setpoint (or the
inability to ever achieve a setpoint) have consistently
been associated with faster rate of clinical progression
to AIDS or death. Accordingly, in these four, one has
already begun to progress clinically, while in the
others both viral load and diversity continue to
increase.
Dr. Jim Mullins, who spoke on viral diversity
at the Conference on the following morning, and was one
of the authors on the dual infection study at the Tenth
Conference on Retroviruses as well, believes that these
data support the University of Washington’s earlier
study.
He pointed out that it isn’t clear “whether
becoming dually infected causes greater damage to the
immune system that leads to faster progression or
whether people who are dually infected are genetically
predisposed to be unable to control viral diversity.
That defect may be the same reason why they become
dually infected in the first place.”
However, known genetic factors predisposing
patients to rapid progression have yet to be noted in
these patients. Furthermore, if these patients do have a
specific immunologic defect that predisposes them to
becoming infected by more than one virus, why haven’t
the researchers observed three, four or even more
strains multiply infecting a patient? Why stop at two
strains?
Although this study was in women sex workers,
if further data support the findings, it may have
important implications for other types of high-risk
behaviour. For example, individuals who become infected
during unsafe ‘sex binges’ with multiple partners
(at a party, club, online or via internet dating over a
weekend) could potentially have a very different
clinical outcome than someone who becomes infected
during the occasional unsafe sexual encounter.
|